Pneumonia, a respiratory disease that kills about 50,000 people in the United States every year, can be caused by many different microbes, including bacteria and viruses. Rapid detection of pneumonia is critical for effective treatment, especially in hospital-acquired cases which are often more severe. However, current diagnostic approaches often take several days to return definitive results, making it harder for doctors to prescribe the right treatment.
MIT researchers have now developed a nanoparticle-based technology that could be used to improve the speed of diagnosis. This type of sensor could also be used to monitor whether antibiotic therapy has successfully treated the infection, says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science and the senior author of the study.
“If the patient’s symptoms go away, then you assume the drug is working. But if the patient’s symptoms don’t go away, then you would want to see if the bacteria is still growing. We were trying to address that issue,” says Bhatia, who is also a member of MIT’s Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science.
Graduate student Colin Buss and recent PhD recipient Jaideep Dudani are the lead authors of the paper, which appears online Nov. 29 in the journal EBioMedicine. Reid Akana, an MIT senior, and Heather Fleming, director of research for Bhatia’s lab, are also authors of the paper.
Sensors in the body
Several years ago, Bhatia and her colleagues developed a diagnostic approach that amplifies a signal from biomarkers already present in the body — specifically, enzymes called proteases, which chop up other proteins. The human genome encodes more than 500 different proteases, each of which targets different proteins.
The team developed nanoparticles coated with peptides (short proteins) that can be chopped up by certain proteases, such as those expressed by cancer cells. When these particles are injected into the body, they accumulate in tumors, if any are present, and proteases there chop the peptides from the nanoparticles. These peptides are eliminated as waste and can be detected by a simple urine test.
“We’ve been working on this idea that measuring enzyme activity could be a new way to peer inside the body,” Bhatia says.
In recent studies, she has shown that this approach can be used to detect different types of cancers, including very small ovarian tumors, which could enable earlier diagnosis of ovarian cancer.
For their new study, the researchers wanted to explore the possibility of diagnosing infection by detecting proteases that are produced by microbes. They began with a species of bacteria called Pseudomonas aeruginosa, which can cause pneumonia and is a particularly common cause of hospital-acquired cases. Pseudomonas expresses a protease called LasA, so the researchers designed nanoparticles with peptides that can be cleaved by LasA.
The researchers also developed a second nanoparticle-based sensor that can monitor the host’s immune response to infection. These nanoparticles are covered in peptides that are cleaved by a type of protease called elastase, which is produced by immune cells called neutrophils.
In some patients with pneumonia, even if an antibiotic clears out the bacteria causing the infection, a chest X-ray may still show inflammation because neutrophils are still active. Using these two sensors together could reveal whether an antibiotic has cleared the infection, in cases where a chest X-ray still shows inflammation after treatment.
“The sensors can help you distinguish between whether there’s an infection and inflammation, versus inflammation and no infection,” Bhatia says. “What we showed in the paper is that when you treat with the right antibiotic, the infection goes down but the inflammation persists.”
The researchers also showed that if they treated mice with an ineffective antibiotic, both bacteria levels and inflammation levels stayed high. This kind of test could help to reveal whether an antibiotic is working, in cases where a patient’s symptoms haven’t improved within a few days.
Diagnosing many infections
For this study, the researchers delivered the nanoparticles intravenously, but they are now working on a powdered version that could be inhaled.
Bhatia envisions that this approach could be used to determine whether a patient has bacterial or viral pneumonia, which would help doctors to decide if the patient should be given antibiotics or not. The definitive test, growing a bacterial culture from coughed up mucus, takes several days, so doctors base their decisions on the patients’ symptoms and X-ray imaging — a process that may not always be accurate.
To create a more comprehensive diagnostic, Bhatia’s lab is now working on adding peptides that could interact with proteases from other types of bacteria that cause pneumonia, as well as proteases that the host immune system produces in response to either viral or bacterial infection. The researchers are also working on sensors that could easily distinguish between active and dormant forms of tuberculosis.
Bhatia and others have started a company called Glympse Bio that has licensed the protease sensing technology and is now working on developing protease sensors for possible use in humans. Next year, they plan to begin a phase I clinical trial of a sensor that can detect liver fibrosis, an accumulation of scar tissue that can lead to cirrhosis.
The Latest on: Diagnosing infection
via Google News
The Latest on: Diagnosing infection
- 6 Endometriosis Symptoms That Make it Hard to Diagnose on February 20, 2019 at 10:02 am
Women with endometriosis can also have symptoms involving the bladder, Gersh noted. Such symptoms can feel like a bladder infection, and may include urgency and a sense of fullness in the bladder. “En... […]
- New test can diagnose killer infection in minutes to save lives on February 19, 2019 at 6:30 pm
A new rapid test for sepsis which can give a result within three minutes has been developed by scientists. The test could save thousands of lives from the deadly condition and experts hope it will be ... […]
- Gut microbiome imbalances may help diagnose, track lupus on February 19, 2019 at 2:38 pm
They could then diagnose and track the disease's progress starting from ... This approach may also be hurting the body's immune system, making it harder to fight infections caused by lupus. RELATED Se... […]
- Common yeast infection pill tied to miscarriages on February 19, 2019 at 1:44 pm
and many women who miscarry early in pregnancy may not necessarily have this event detected or diagnosed by a doctor. Still, the results underscore the importance of pregnant women seeking alternative... […]
- Boy (11) diagnosed with TB after father picked up infection from contaminated prisoners at work on February 19, 2019 at 6:36 am
An 11-year-old schoolboy, who had become a carrier of latent tuberculosis as a result of an infection picked up by his father from contaminated prisoners in his work as a prison officer, has been awar... […]
- Interstitial Cystitis: Diagnosis and Management on February 19, 2019 at 2:19 am
Symptoms frequently appear to be like those of a bladder infection but the urine analysis is usually ... On average, before the correct diagnosis is made, an IC patient sees six different healthcare p... […]
- HIV diagnosis: Tests for HIV infection on February 19, 2019 at 1:29 am
HIV is a virus that affects your immunity system and if you don’t treat this virus, it can kill and infect your CD4 cells. Less number of CD4 cells will make you susceptible to develop different infec... […]
- MU student diagnosed with tuberculosis on February 18, 2019 at 1:35 pm
COLUMBIA — An unidentified MU student has been diagnosed with active tuberculosis ... "I would definitely be worried because they could be exposed to the active infection or even the latent one that m... […]
- New protocol could ease diagnosis of bacterial infections in infants on February 18, 2019 at 8:14 am
A new protocol could help emergency room physicians to rule out life-threatening bacterial infections among infants up to 2 months of age who have fevers, potentially eliminating the need for spinal t... […]
via Bing News